QUICKLINKS AND VIEW OPITONS

Posted by .(JavaScript must be enabled to view this email address)
Sunday, June 10, 2018 11:34 am Email this article

“Statin treatment increased the risk of type 2 diabetes by 46%, attributable to decreases in insulin sensitivity and insulin secretion,” concludes a 2015 study that followed 8,749 non-diabetic participants, 45– to 73-years-old, for 5.9 years.

Insulin sensitivity and insulin secretion decreased

Insulin sensitivity decreased 24%, insulin secretion decreased 12%

Insulin sensitivity was decreased by 24% and insulin secretion by 12% in people on statins compared with people who were not on statins.

Dose-Dependent

Risk was dose-dependent

The risk was dose-dependent for simvastatin (Zocor) and atorvastatin (Lipitor).

Subjects

Subjects: 8,749 non-diabetic participants, 45–73 years-old, followed up for 5.9 years

The study involved 8,749 non-diabetic participants, aged 45–73 years, who were followed up for 5.9 years.